Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
LYEL on Nasdaq
Shares outstanding
19,277,111
Price per share
$16.24
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
650,353
Total reported value
$10,561,733
% of total 13F portfolios
0%
Share change
-1,790,320
Value change
-$15,728,473
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund IX, L.P. 13% $16,102,995 36,597,716 Robert Nelsen 31 Dec 2024
Foresite Capital Fund IV, L.P. 9.2% +36% $11,951,232 +$3,380,520 27,161,892 +39% James B. Tananbaum 31 Mar 2025
BlackRock, Inc. 4.5% $5,836,982 13,265,869 BlackRock, Inc. 31 Dec 2024
Explore Investments LLC/DE 5.4% $9,202,330 1,040,964 Explore Investments LLC 25 Jul 2025

As of 30 Sep 2025, 2 institutional investors reported holding 650,353 shares of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL). This represents 3.4% of the company’s total 19,277,111 outstanding shares.

Institutional Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 650,353 $10,561,733 -$15,728,473 $16.24 2
2025 Q2 2,440,673 $21,579,143 -$465,374,552 $8.84 6
2025 Q1 152,354,676 $81,759,018 +$815,948 $0.54 111
2024 Q4 150,286,895 $95,884,564 +$14,590,227 $0.64 101
2024 Q3 128,413,620 $176,562,816 -$7,308,646 $1.38 115
2024 Q2 133,377,133 $193,968,531 -$1,417,363 $1.45 114
2024 Q1 132,843,101 $296,875,323 +$4,211,832 $2.23 124
2023 Q4 127,208 $255,964 $2.02 2
2023 Q3 122,436,727 $179,982,746 +$185,145 $1.47 100
2023 Q2 122,179,983 $388,530,224 +$15,242,932 $3.18 97
2023 Q1 117,471,505 $277,203,801 +$818,441 $2.36 95
2022 Q4 116,611,487 $404,587,610 +$13,810,470 $3.47 92
2022 Q3 112,285,393 $823,071,578 +$50,660,796 $7.33 86
2022 Q2 105,556,240 $688,252,221 +$42,217,102 $6.52 71
2022 Q1 99,451,185 $502,296,530 +$55,150,752 $5.05 75
2021 Q4 84,539,142 $654,426,000 -$25,699,393 $7.74 74
2021 Q3 82,534,412 $1,221,509,324 +$57,610,023 $14.80 61
2021 Q2 78,055,048 $1,267,456,800 +$1,267,456,786 $16.24 51